title: Myocardial perfusion reserve in spared myocardium: correlation with infarct size and left ventricular ejection fraction.
abstract: OBJECTIVE
  Left ventricular ejection fraction (LVEF) after myocardial infarction is considered to be determined by the size of the infarction and residual function of the spared myocardium. Myocardial perfusion reserve (MPR) has been shown to be a strong prognostic factor in patients with ischaemic heart failure, even stronger than LVEF. In the present study, the interrelationship between MPR, LVEF and infarct size was investigated.
  
  
  METHODS
  In total, 102 patients with a prior history of myocardial infarction were included. All underwent rest and stress (13)N-ammonia and gated (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography (PET) for evaluation of myocardial ischaemia and viability. FDG polar maps were used to determine the size of the infarction. The LVEF was obtained by gated (18)F-FDG PET or another available method within 3 months of the PET scan. MPR was obtained per segment in the spared myocardium.
  
  
  RESULTS
  The mean age of the subjects was 68 ± 12 years. Global MPR was 1.63 ± 0.51. The mean LVEF was 36 ± 10 % and mean infarct size 23.72 ± 14.8 %. A linear regression model was applied for the analysis considering the LVEF as a dependent variable. All risk factors, mean stress flow, infarct size and MPR were entered as variables. The infarct size (p < 0.001) and MPR (p = 0.04) reached statistical significance. In a multivariate model MPR had a stronger correlation with LVEF than infarct size.
  
  
  CONCLUSIONS
  In patients with a prior history of myocardial infarction, LVEF is not just related to infarct size but also to MPR in the spared myocardium.
authors.affiliation: Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, PO Box 30001, 9700 RB Groningen, The Netherlands.
authors.forename: Luis Eduardo
authors.initials: LE
authors.lastname: Juárez-Orozco
authors.forename: Julius
authors.initials: J
authors.lastname: Glauche
authors.forename: Erick
authors.initials: E
authors.lastname: Alexanderson
authors.forename: Clark J
authors.initials: CJ
authors.lastname: Zeebregts
authors.forename: Hendrikus H
authors.initials: HH
authors.lastname: Boersma
authors.forename: Andor W J M
authors.initials: AW
authors.lastname: Glaudemans
authors.forename: Rudi A
authors.initials: RA
authors.lastname: Dierckx
authors.forename: Dirk J
authors.initials: DJ
authors.lastname: van Veldhuisen
authors.forename: René A
authors.initials: RA
authors.lastname: Tio
authors.forename: Riemer H J A
authors.initials: RH
authors.lastname: Slart
mesh_terms: D000368:Aged; D005260:Female; D019788:Fluorodeoxyglucose F18; D006321:Heart / Q000000981:diagnostic imaging*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000000981:diagnostic imaging*; D055414:Myocardial Perfusion Imaging; D049268:Positron-Emission Tomography; D013318:Stroke Volume; D018754:Ventricular Dysfunction
chemical_list: D019788:Fluorodeoxyglucose F18
references.citation: N Engl J Med. 2003 Sep 11;349(11):1027-35
references.pmid: 12968086
references.citation: J Am Coll Cardiol. 2004 Feb 18;43(4):534-41
references.pmid: 14975460
references.citation: J Nucl Med. 1995 Jan;36(1):153-8
references.pmid: 7799070
references.citation: J Am Coll Cardiol. 1990 Apr;15(5):1032-42
references.pmid: 2312957
references.citation: J Nucl Med. 2011 May;52(5):726-32
references.pmid: 21498538
references.citation: Heart. 1999 May;81(5):478-82
references.pmid: 10212164
references.citation: J Nucl Med. 1995 Nov;36(11):2138-47
references.pmid: 7472611
references.citation: J Nucl Med. 2009 Feb;50(2):214-9
references.pmid: 19164219
references.citation: Am J Cardiol. 2010 Sep 1;106(5):635-40
references.pmid: 20723637
references.citation: Circulation. 2002 Jan 15;105(2):186-93
references.pmid: 11790699
references.citation: Basic Res Cardiol. 1993;88 Suppl 1:81-95
references.pmid: 8357337
references.citation: J Am Coll Cardiol. 1999 Sep;34(3):618-20
references.pmid: 10483939
references.citation: N Engl J Med. 2007 Feb 22;356(8):830-40
references.pmid: 17314342
references.citation: J Am Coll Cardiol. 2000 Jan;35(1):19-28
references.pmid: 10636254
references.citation: J Nucl Med. 1992 Jul;33(7):1255-62
references.pmid: 1613561
references.citation: J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):34A-40A
references.pmid: 8104205
references.citation: Neth Heart J. 2009 Dec;17(12):470-4
references.pmid: 20087450
references.citation: JACC Cardiovasc Interv. 2010 Dec;3(12):1284-91
references.pmid: 21232723
references.citation: J Thorac Cardiovasc Surg. 2007 Dec;134(6):1540-7
references.pmid: 18023680
references.citation: J Cardiovasc Pharmacol. 1998;32 Suppl 1:S46-51
references.pmid: 9731695
references.citation: Microcirculation. 2003 Apr;10(2):113-26
references.pmid: 12700580
references.citation: J Nucl Med. 1994 Jun;35(6):989-98
references.pmid: 8195886
references.citation: J Nucl Med. 1989 Mar;30(3):359-66
references.pmid: 2786939
references.citation: J Nucl Med. 2011 Jun;52(6):873-9
references.pmid: 21571798